FY2026 EPS Estimates for Exelixis Raised by Leerink Partnrs
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs increased their FY2026 EPS estimates for shares of Exelixis in a research note issued on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will post earnings of $2.56 per share for the year, up from their prior […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs increased their FY2026 EPS estimates for shares of Exelixis in a research note issued on Wednesday, March 26th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will post earnings of $2.56 per share for the year, up from their prior […]
